OTC SquawkOTC Squawk
Log inSign up
OTC SquawkOTC Squawk
Log inSign up
FeedDiscoverTickersNotificationsProfileSign in to squawk

OTC Squawk is not affiliated with, endorsed by, or sponsored by OTC Markets Group Inc. All trademarks are the property of their respective owners.

$NWBO

OTCQB

NORTHWEST BIOTHRPUTCS INC

Sign in to follow
OTC
Exchange
Healthcare
Sector
Biotechnology
Industry
Common Stock
Security type
1.68B
Shares outstanding
66737P600
CUSIP
NWBO
Symbol

Company and security reference data from OTC Markets Group.

SEC filings
Last trade

Catalysts

  • 10-Q
    Quarterly report
    SEC · Aug 14, 2026
  • 8-K
    Current report
    SEC · Jul 31, 2026
  • 424B5
    Prospectus supplement
    SEC · Jul 31, 2026
  • 8-K
    Current report
    SEC · Jul 20, 2026
  • 10-Q
    Quarterly report
    SEC · May 15, 2026
  • EFFECT
    Registration effective
    SEC · Apr 20, 2026
  • POS AM
    View filing
    SEC · Apr 16, 2026
  • 10-K
    Annual report
    SEC · Apr 15, 2026

DD entries are user-generated due diligence, not investment advice. Moderated. Filings link to sec.gov.

Related tickers

  • $XPHYFXphyto Therapeutics Corp
  • $CGCCanopy Growth Corp
  • $MMNFFMedMen Enterprises Inc
  • $KALYKALI INC
  • $SNDLSNDL Inc

Dilution indicators

No level shown - warrant disclosures, preferred stock disclosures and convertible note disclosures could not be read reliably from this filing. The extracted facts are below.

Shares outstanding
1,669,300,000
Shares authorized
2,600,000,000
Authorized headroom
930,700,000 (0.6x outstanding)
Convertible note principal
Not read reliably
Conversion discount
Not read reliably
Shares issuable from convertibles
Not read reliably
Warrants outstanding
Not read reliably
Preferred shares outstanding
637,614
Preferred conversion shares
Not read reliably

From 10-Q filed Aug 14, 2026View filing

How this is calculated

Level = disclosed potential new shares (warrants + preferred conversion shares + shares issuable from convertible notes, where the filing states them) divided by shares outstanding:

under 10% = Low · 10-50% = Moderate · 50-200% = Elevated · over 200% = Substantial

Only figures stated explicitly in the filing are used - nothing is estimated. A level is shown only when the share count was read with high confidence AND each of convertibles, warrants, and preferred stock was either clearly disclosed or affirmatively stated as none by the filing. If any of the three could not be read reliably, no level is shown at all - partial data never produces a label. Authorized headroom is shown as a separate fact and is not part of the level. Convertible note principal (dollars) is never converted into shares.

Figures are AI-extracted from the company's own SEC filings and may contain errors - always verify against the linked filing. This is not investment advice.

  • @cryanschadel
    cryanschadel@cryanschadel·30 days ago

    $NWBO wasnt this a nasdaq company at one time?

    BullishBearish
    1

Top contributors

  • 1@Wili
    Wili
    @Wili
    90
    motion
  • 2@TophatTopher
    TophatTopher
    @TophatTopher
    88
    motion
  • 3@otcsetGuy
    otcset Guy
    @otcsetGuy
    87
    motion
  • 4@Stevemcgregor0209
    SteveMcgregor
    @Stevemcgregor0209
    85
    motion
  • 5T
    Russ
    @TheBigRuss77
    84
    motion